Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This study is testing a standard dose of nivolumab in people whose cancer has spread or come back (advanced cancer). Doctors usually work out your dose of nivolumab individually but recent research has found that the same dose could work for everyone.
In this study, the doctors want to find out how safe this dose is alongside ipilimumab and how well it works.
Recruitment start: 11 April 2017
Recruitment end: 31 January 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Samreen Ahmed
Bristol-Myers Squibb
Last reviewed: 1 February 2018
CRUK internal database number: 14711
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
